itraconazole has been researched along with Onychomycosis in 325 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.31) | 18.7374 |
| 1990's | 122 (37.54) | 18.2507 |
| 2000's | 122 (37.54) | 29.6817 |
| 2010's | 56 (17.23) | 24.3611 |
| 2020's | 24 (7.38) | 2.80 |
| Authors | Studies |
|---|---|
| Lipner, SR; Wang, Y | 2 |
| Gupta, AK; Talukder, M; Venkataraman, M | 2 |
| Abd-Allah, D; Abd-Elhamid, N; Elkholy, B; Nasr, M | 1 |
| Hiruma, M; Kano, R; Noguchi, H | 1 |
| Lipner, SR; Miller, RC | 1 |
| Amin, AA; Nasif, GA; Ragaie, MH | 1 |
| Bamimore, MA; Gupta, AK; Venkataraman, M | 1 |
| Nagesha, PC; Rangegowda, SM; Ravikumar, BC; Shetty, P; Vinay, KN | 1 |
| Rana, D; Rao, BK; Saleem, MA; Shah, RR; Sharif, S; Waqas, N | 1 |
| Babaev, M; Daniel, CR; Farhi, R; Foley, KA; Gupta, AK; Hermush, V; Kamshov, S; Shemer, A | 1 |
| Bramono, K; Kusumawardhani, HT; Marissa, M; Menaldi, SL; Miranda, E; Oktarina, C; Surya, D; Widaty, S | 1 |
| Bamimore, MA; Foley, KA; Gupta, AK; Piguet, V; Shear, NH; Stec, N | 1 |
| Abdollahi, D; Afshar, M; Jafariazar, Z | 1 |
| Bonetti, AF; Domingos, EL; Fávero, MLD; Pontarolo, R; Tonin, FS | 1 |
| Gupta, AK; Piguet, V; Piraccini, BM; Shear, NH; Stec, N; Summerbell, RC; Tosti, A | 1 |
| Abd Elhameed, MI; Abu El-Hamd, M; Saleh, R; Shalaby, MFM | 1 |
| El-Hawary, EE; Fawzy, MM; Nofal, A | 1 |
| Geizhals, S; Lipner, SR | 1 |
| Gupta, AK; Quinlan, EM; Summerbell, RC; Venkataraman, M | 1 |
| Dyląg, M; Hryncewicz-Gwóźdź, A; Jagielski, T | 1 |
| Corrêa, C; Fuentefria, AM; Goldani, LZ; Heidrich, D; Rosa, PD; Scroferneker, ML; Vettorato, G | 1 |
| Babaev, M; Daniel, CR; Farhi, R; Foley, KA; Gupta, AK; Kamshov, A; Shemer, A | 1 |
| Chang, WL; Chiu, HY; Shiu, MN; Tsai, TF; Tsai, YW | 1 |
| Han, X; Hu, YQ; Hu, YX; Hunag, SY; Liu, KX; Lu, Y; Mao, ZH; Wu, Z; Yang, YM; Zhong, ZM; Zhou, ST; Zhou, XY | 1 |
| Li, X; Shi, Y; Tao, Y; Xu, H; Yu, J; Zhang, L | 1 |
| Lipner, SR; Scher, RK | 1 |
| Bei, H; Chen, SP; Fang, Q; Liu, C; Liu, PM; Luo, WX; Wu, YX; Zeng, HY; Zhang, L | 1 |
| Li, Q; Sun, Y; Wang, A; Yue, X | 1 |
| Chan, JFW; Chan, KF; Cheung, M; Fung, KSC; Lai, CKC; Lau, ECL; Lau, SKP; Lee, CY; Li, X; Ng, RHY; Ngan, AHY; Tang, JYM; Tsang, CC; Woo, PCY | 1 |
| Foley, KA; Gupta, AK; Mays, RR; Piguet, V; Shear, NH | 1 |
| Hamed Khater, M; Khattab, FM | 1 |
| Fata, A; Najafzadeh, MJ; Naseri, A | 1 |
| Baudraz-Rosselet, F; Lurati, M; Monod, M | 1 |
| Höpfl, R; Huemer, HP; Martini, K; Müller, H | 1 |
| Bulger, L; Maddin, S; Quiring, J | 1 |
| Chen, H; Chen, M; Liao, W; Pan, W; Zhou, J | 1 |
| Hata, Y | 1 |
| de Sá, DC; Lamas, AP; Tosti, A | 1 |
| Atsuda, K; Echizen, H; Inamoto, N; Kubo, H; Machida, M; Ono, N; Saito, H; Shibata, S; Shinozaki, K; Takahashi, H; Wada, N | 1 |
| Baudraz-Rosselet, F; Bontems, O; Monod, M; Verrier, J | 1 |
| Jim, SC; Kircik, LH; Routt, ET; Zeichner, JA | 1 |
| Mazumder, B; Pal, P; Ray, S; Thakur, RS | 1 |
| Sun, PL; Wang, YJ | 1 |
| Gunasekara, TA; Nagahawatte, A; Ranawaka, RR | 1 |
| Pajaziti, L; Vasili, E | 1 |
| Abastabar, M; Armaki, MT; Falahati, M; Farahyar, S; Ghasemi, Z; Ghojoghi, A; Hedayati, MT; Hoseinnejad, A; Roudbary, M | 1 |
| Guanziroli, E; Moschin, A; Rizzitelli, G; Sangalli, R; Veraldi, S | 1 |
| de Silva, SH; Gunasekara, TA; Nagahawatte, A; Ranawaka, RR; Weerakoon, HS | 1 |
| Bhatia, N; Caldwell, B; Elewski, BE; Gupta, AK; Kircik, LH; Pariser, DM; Rosen, T; Tosti, A | 1 |
| Rosen, T; Stein Gold, LF | 1 |
| Chanda, S; Coronado, D; Del Rosso, J; Zane, LT | 1 |
| Hiruma, M; Ihn, H; Makino, K; Miyashita, A; Miyata, K; Noguchi, H | 1 |
| Li, Y; Xu, J; Zhao, JY; Zhuo, FL | 1 |
| García-Romero, MT; Solís-Arias, MP | 1 |
| Balta, I; Oz, A; Oz, Y; Qoraan, I | 1 |
| de Silva, SH; Ranawaka, RR | 1 |
| Elizondo, J; Krasaeath, R | 1 |
| Feng, X; Ran, Y; Xiong, X | 1 |
| Ota, M | 1 |
| Blandizzi, C; Bresci, F; Del Tacca, M; Di Paolo, M; Guidi, B; Tuccori, M | 1 |
| Batinac, T; Biljan, D; Kujundzić, M; Petranović, D; Troselj-Vukić, B; Zamolo, G | 1 |
| de Silva, N; Ragunathan, RW; Ranawaka, RR | 1 |
| Barber, J; Barber, K | 1 |
| Chiaratti, A; Harak, H; Veraldi, S | 1 |
| Mohagheghzahed, G; Sadighha, A | 1 |
| de Berker, D | 1 |
| Ferrari, J | 2 |
| Fan, YM; Huang, WM; Li, W; Zhang, GX | 1 |
| Budihardja, D; Freund, V; Mayser, P | 1 |
| Amichai, B; Davidovici, B; Grunwald, MH; Shemer, A; Trau, H | 1 |
| Brown, SJ | 1 |
| Bueno, JG; Gallego, M; Martinez, C; Mesa, AC; Sanclemente, G; Zapata, B | 1 |
| Harada, T; Ishizaki, S; Kobayashi, K; Ninomiya, J; Sawada, M; Tanaka, M | 1 |
| Bieber, T; Björkhem, I; Diczfalusy, U; Lütjohann, D; Marinova, M; Oldenburg, J; Schneider, B; von Bergmann, K | 1 |
| Barabino, G; Machetti, M; Perotti, M; Persi, A; Zotti, M | 1 |
| Chen, GS; Lan, CC; Wu, CY | 1 |
| Baudraz-Rosselet, F; Bontems, O; Lurati, M; Monod, M; Ruffieux, C | 1 |
| Piraccini, BM; Sisti, A; Tosti, A | 1 |
| Daniel, CR; Jellinek, NJ | 1 |
| Vera-Cabrera, L; Welsh, E; Welsh, O | 1 |
| Iwasaki, T; Kaneshima, T; Kano, R; Namitome, K; Nishifuji, K; Sekiguchi, M | 1 |
| Harada, T | 1 |
| Luo, D; Xu, J; Yin, Z | 1 |
| Barabino, G; Machetti, M; Parodi, A; Persi, A; Zotti, M | 1 |
| Choi, JS; Kim, IS; Lee, JW; Moon, NJ; Park, KY; Seo, SJ; Suh, MK | 1 |
| Arabatzis, M | 1 |
| Bergman, R; Izhak, OB; Mayer, E | 1 |
| Ananiev, J; Cardoso, JC; Ginter-Hanselmayer, G; Guarneri, C; Gulubova, M; Hristova, R; Kanazawa, N; Martino, G; Nenoff, P; Nocheva, D; Penev, PK; Taneva, T; Tchernev, G; Zisova, LG | 1 |
| Fothergill, A; Jo Siu, WJ; Nakamura, T; Pillai, R; Senda, H; Sone, D; Tatsumi, Y | 1 |
| Glad'ko, VV; Tarasenko, GN | 1 |
| Elmer, KB; Elston, DM; Libow, LF | 1 |
| Chen, HH; Liao, YH | 1 |
| Curran, D; Evans, EG; Paul, C; Sigurgeirsson, B | 1 |
| Christensen, J; Dupont, E; ØStergaard, K | 1 |
| Darkes, MJ; Goa, KL; Scott, LJ | 1 |
| Baran, R; Gupta, AK; Summerbell, R | 1 |
| Chen, H; Liu, L; Wu, Y; Zeng, J; Zheng, Y; Zhu, Z | 1 |
| Botek, G | 1 |
| Boyle, J; Roberts, DT; Taylor, WD | 1 |
| Amaya, K; Arikian, S; Casciano, J; Doyle, J; Haspel, M; Kahler, K; Shear, N | 1 |
| Jones, ED | 1 |
| Jain, S; Sehgal, VN | 3 |
| Dowlati, Y; Firooz, A; Khamesipour, A | 1 |
| Balkou, P; Bolbasis, I; Christofidou, E; Fragouli, E; Georgala, S; Ioannides, D; Kalogeromitros, D; Karistinou, A; Katoulis, AC; Katsambas, AD; Polydorou, D; Rigopoulos, D | 1 |
| Gupta, AK; Ryder, JE | 1 |
| Cooper, EA; Ginter, G; Gupta, AK | 1 |
| Scheinfeld, NS; Weinberg, JM | 1 |
| Biton, A; Chetov, T; Cohen, AD; Medvesovsky, E; Naimer, S; Shai, A; Shalev, R; Vardy, DA | 1 |
| Safdar, A | 1 |
| Akbar, TM; Aman, S; Haroon, TS; Hussain, I; Jahangir, M | 1 |
| Reinel, D | 1 |
| Seebacher, C | 3 |
| Gupta, AK; Johnson, AM; Ryder, JE | 1 |
| Aragane, Y; Kawada, A; Tezuka, T | 1 |
| Armstrong, D; Bondar, G; Werschler, WP | 1 |
| del Palacio, A; Hernando, S; Menéndez, F; Rodríguez, ME | 1 |
| Thomas, CL | 1 |
| Watanabe, S | 1 |
| Lagana, FJ | 1 |
| Wenig, JA | 2 |
| Joseph, WS | 2 |
| Ratajczak-Stefańska, V | 1 |
| Ben-Ami, R; Brenner, S; Levtov, S; Srebrnik, A | 1 |
| Ghilardi, A; Massai, L; Romano, C | 1 |
| Hattori, N; Li, W; Misawa, Y; Okuzumi, K; Shirai, A; Sugiura, Y; Tamaki, K; Yokoyama, K | 1 |
| Carver, SM; Fett, DD; Lederle, FA; Nelson, D; Warshaw, EM; Webster, N; Zielke, GR | 1 |
| Nieber, K; Rufke, C | 1 |
| Chowdhury, AH; Hoque, MM; Khan, RM; Mamun, SA; Sikder, AU | 1 |
| Asilian, A; Darougheh, A; Davami, M; Enshaieh, SH; Iraji, F; Shahmoradi, Z; Siadat, AH; Vaez, A; Yoosephi, A | 1 |
| Crawford, F; Ferrari, J | 2 |
| Dai, XY; Hu, Y; Hua, HK; Qi, J; Sun, H; Wei, L; Yang, LJ; Zheng, Y | 1 |
| Goksugur, N; Karabay, O; Parlak, AH | 1 |
| Hiruma, M | 1 |
| Avner, S; Baruch, K; Henri, T; Nir, N | 1 |
| Adamski, Z; Maleszka, R | 1 |
| Gover, MD; Gupta, AK; Lynde, CW | 1 |
| Barros, MEDS; Hamdan, JS; Santos, DA | 1 |
| Sellart-Altisent, M; Torres-Rodríguez, JM | 1 |
| Bonifaz, A; Fierro, L; Paredes, V | 1 |
| de Assis Santos, D; Figueiredo, VT; Hamdan, JS; Resende, MA | 1 |
| Guilhermetti, E; Shinobu, CS; Svidzinski, TI; Takahachi, G | 1 |
| Fukunami, M; Kioka, H; Okamoto, J | 1 |
| Mididoddi, PK; Repka, MA; Trey, SM; Wicks, DA | 1 |
| Can, F; Demirbilek, M; Sarifakioglu, E; Seçkin, D | 1 |
| Bieber, T; Björkhem, I; Diczfalusy, U; Dullens, S; Gerdsen, R; Lütjohann, D; Neuvonen, PJ; Plat, J; Schneider, B; von Bergmann, K | 1 |
| Chan, AK; Chang, CH; Kurth, T; Orav, JE; Young-Xu, Y | 1 |
| Hernández-Hernández, F; López-Martínez, R; Manzano-Gayosso, P; Méndez-Tovar, LJ; Millan-Chiu, B; Mondragón-González, R; Velásquez-Hernández, V | 1 |
| Ginter-Hanselmayer, G; Smolle, J; Weger, W | 1 |
| Hiruma, M; Muto, M; Sugita, T; Takahata, Y | 1 |
| Kaplan, B; Nathansohn, N; Shemer, A; Trau, H | 1 |
| Abe, M; Abe, S; Ikeda, R; Maeasaki, S; Mohri, S; Nishiyama, Y; Oguri, T; Shibuya, K; Toshio, K; Uno, J; Watanabe, S | 1 |
| Cárdenes, D; Carrillo-Muñoz, AJ; del Valle, O; Eraso, E; Giusiano, G; Guardia, C; Guarro, J; Hernández-Molina, JM; Quindós, G; Tur-Tur, C | 1 |
| Maeda, M | 1 |
| Ceballos, JD; Erchiga, VC; Falcón, CS; Falcón, Mdel M; Florencio, VD; xOrtega, SC | 1 |
| Bräutigam, M; Nolting, S; Schopf, RE; Weidinger, G | 2 |
| Neumann, HA | 1 |
| Arenas, R; Domínguez-Cherit, J; Fernández, LM | 1 |
| Achten, G; André, J; De Doncker, P; Laporte, M; Ledoux, M; Stouffs-Van Hoof, F; Van Cutsem, J; Wiame, L | 1 |
| Bergman, W; Rutten, FF | 1 |
| Roberts, DT | 1 |
| Arikian, SR; Einarson, TR; Kobelt-Nguyen, G; Schubert, F | 1 |
| Georgii, A; Korting, HC; Ollert, MW; Schäfer-Korting, M; Zienicke, H | 1 |
| Rosen, T | 1 |
| Balmus, KJ; Lavrijsen, AP; Nugteren-Huying, WM; Roldaan, AC; Stricker, BH; van 't Wout, JW | 1 |
| Hay, RJ | 2 |
| De Doncker, P; Roseeuw, D | 1 |
| De Doncker, P; Decroix, J; Dockx, P; Heremans, A; Jacqmin, P; Odds, F; Piérard, GE; Roelant, D; Roseeuw, D; Woestenborghs, R | 1 |
| De Doncker, P; Dockx, P; Roseeuw, D; Van Lint, J | 1 |
| Bardazzi, F; Colombo, MD; Piraccini, BM; Stinchi, C; Tosti, A; Venturo, N | 1 |
| Smith, GN | 1 |
| Phillips, P | 1 |
| Karvonen, J; Ruutu, P | 1 |
| Aly, R; Daniel, CR; Odom, R | 1 |
| Baran, R; de Doncker, P | 1 |
| De Backer, M; De Keyser, P; De Vroey, C; Lesaffre, E | 1 |
| Odom, RB | 1 |
| Brodell, RT | 1 |
| Arrese, JE; De Doncker, P; Jacqmin, P; Pierard, GE; Pierard-Franchimont, G; Van de Velde, V | 1 |
| Jones, HE; Zaias, N | 1 |
| André, J; De Doncker, P; Luyten, C; Walraevens, C | 1 |
| Fernández-Redondo, V; Ginarte, M; Pereiro, M; Toribio, J | 1 |
| Kirshbaum, BA | 1 |
| Del Rosso, JQ | 2 |
| De Doncker, P; Dubois, DJ; Eggleston, A; Gupta, AK; Haneke, E; Tormans, G; Van Doorslaer, EK; Van Rossem, K | 1 |
| Suarez, S | 1 |
| Lorenzi, S; Piraccini, BM; Stinchi, C; Tosti, A | 1 |
| De Doncker, P; Gupta, AK; Sauder, DN; Scher, RK; Shear, NH | 1 |
| Piérard, GE; Piérard-Franchimont, C | 1 |
| Baran, RL; De Doncker, PR; Decroix, J; Degreef, HJ; Gupta, AK; Havu, V; Piérard, GE; Roseeuw, DI; Rosen, T; Scher, RK | 1 |
| Aly, R; Daniel, CR; DeVillez, R; Elewski, BE; Jacko, M; Moskovitz, BL; Odom, RB; Oleka, N; Scher, RK; Zaias, N | 1 |
| Heikkilä, H; Stubb, S | 2 |
| Brandt, H; Havu, V; Heikkilä, H; Hollmen, A; Oksman, R; Piepponen, T; Rantanen, T; Saari, S; Stubb, S; Turjanmaa, K | 2 |
| Bonifaz, A; Carrasco-Gerard, E; Saúl, A | 1 |
| Aly, R; Daniel, R; Elewski, BE; Jacko, ML; Jones, HE; Odom, RB; Scher, RK; Zaias, N | 1 |
| Hull, PR | 1 |
| Richardson, MD | 1 |
| Epstein, E | 2 |
| Piérard, GE | 1 |
| Hecker, D | 1 |
| Elewski, BE | 3 |
| Doncker, PD; Gupta, AK; Heremans, A; Marynissen, G; Stoffels, P | 1 |
| Andersen, W; Kramer, KE; Yaar, M | 1 |
| Hernanz Hermosa, JM; Lázaro Ochaita, P | 1 |
| Cerri, A; Crosti, C; Gianni, C | 3 |
| Liao, W; Wen, H; Wu, J | 1 |
| Scher, RK; Seeburger, J | 1 |
| André, J; Baran, R; Daniel, CR; De Doncker, P; Gupta, AK; Haneke, E; Scher, RK | 1 |
| Evans, EG | 2 |
| Hazen, KC | 1 |
| Katz, HI | 1 |
| Bräutigam, M | 1 |
| De Backer, M; De Keyser, P; De Vroey, C; Lesaffre, E; Scheys, I | 1 |
| Bootman, JL | 1 |
| De Doncker, P; Haneke, E; Heremans, A; Tajerbashi, M | 1 |
| Warnock, DW | 1 |
| Jimenez, T; López-Jodra, O; Madrenys-Brunet, N; Siddat, M; Torres-Rodríguez, JM | 1 |
| Colombo, MD; Piraccini, BM; Stinchi, C; Tosti, A | 1 |
| Bräutigam, M; Nolting, S; Weidinger, G | 1 |
| Campbell, I; Gontijo, B; Marques, SA; Ramos-e-Silva, M; Veloso, ST; Zaitz, C | 1 |
| Difonzo, EM; Miracco, C; Romano, C | 1 |
| Abeck, D; Haneke, E; Ring, J | 1 |
| Hiruma, M; Kawai, M; Maeng, DJ; Ogawa, H; Takimoto, R | 1 |
| Ito, Y; Ninomiya, J; Takiuchi, I; Teramoto, T; Yamazaki, K | 1 |
| Tanuma, H | 1 |
| Angello, JT; Jan, SA; Voytovich, RM | 1 |
| Gupta, AK | 3 |
| Evans, EG; Sigurgeirsson, B | 1 |
| Ellis, MR; Kane, KY | 1 |
| Gebauer, S; Haustein, UF; Nenoff, P; Wolf, T | 1 |
| Kane, MP; Tom, CM | 1 |
| Degreef, H; del Palacio, A; Ginter, G; Mygind, S; Pinto Soares, A; Zuluaga de Cadena, A | 1 |
| Matsumoto, T; Nishiyama, S; Tanuma, H | 1 |
| Chen, J; Liao, W; Wen, H; Wu, J; Yao, Z | 1 |
| Albreski, DA; Gross, EG | 1 |
| Church, L; Warrick, D | 1 |
| Li, RY; Wang, AP; Wang, DL; Wang, R | 1 |
| Hsu, S; Kornbleuth, S | 1 |
| De Doncker, P; Gupta, AK | 1 |
| Kejda, J | 1 |
| Aly, R; Cel Rosso, JQ; Daniel, CR; De Doncker, P; Elewski, BE; Gupta, AK; Jacko, M; Marynissen, G; Meuleneers, L; Moskovitz, B; Odom, RB; Rosen, T; Scher, RK; Shear, N; Verspeelt, J | 1 |
| Albreski, DA; Gross, EG; Gupta, AK | 1 |
| De Rosso, JQ; Gupta, AK | 2 |
| De Doncker, P | 1 |
| Arrese, JE; Piérard, GE; Piérard-Franchimont, C | 3 |
| Del Rosso, JQ; Gupta, AK | 2 |
| Gupta, AK; Lambert, J | 1 |
| Gupta, AK; Shear, NH | 1 |
| De Doncker, P; de Prost, Y; Degreef, H; Delescluse, J; Gupta, AK; Marynissen, G; Nolting, S; Theissen, U; Wallace, R | 1 |
| Berg, CL; Carr-Locke, DL; Soetikno, RE; Talwalkar, JA | 1 |
| Gee, SL; Mehregan, DR | 1 |
| Korting, HC; Niewerth, M | 1 |
| Billstein, S; di Fonzo, E; Evans, EG; Goodfield, MJ; Rantanen, T; Ruzicka, T; Sigurgeirsson, B; Vermeer, BJ | 1 |
| De Cuyper, C; Hindryckx, PH | 1 |
| Chong, LY; Ho, HH; Leung, CY; Tang, WY; Wong, TW | 1 |
| Adachi, M; Hattori, N; Ichinohe, M; Iozumi, K; Kaneko, T; Shimozuma, M | 1 |
| Huang, PH; Paller, AS | 1 |
| Bradley, MC; Elewski, BE; Ghannoum, MA; Isham, N; Leidich, S | 1 |
| Glick, B; Rebell, G; Zaiac, MN; Zaias, N | 1 |
| Takasuka, T | 1 |
| Gupta, AK; Konnikov, N; Lynde, CW | 2 |
| Meis, JF; Verweij, PE | 1 |
| Bassler, M; Rodgers, P | 1 |
| Agaoglu, C; Alpay, K; Bahadir, S; Cimsit, G; Inalöz, HS; Parlat, P | 1 |
| Adachi, M; Hattori, N; Iozumi, K; Kaneko, T; Shimozuma, M; Tamaki, K | 1 |
| Jansen, R; Redekop, WK; Rutten, FF | 1 |
| Gregurek-Novak, T; Gupta, AK | 1 |
| Khosravi, AR; Mansouri, P | 1 |
| Ahmad, SR; Leissa, BG; Singer, SJ | 1 |
| Paccagnini, E; Pelliccia, L; Romano, C | 1 |
| Difonzo, EM; Paccagnini, E; Romano, C | 1 |
| Hiruma, M; Kobayashi, M; Matsushita, A; Ogawa, H | 1 |
| Jonkers, GJ; Langers, AM | 1 |
| Cardo, PP; Fiallo, P | 1 |
| De Doncker, P; Gupta, AK; Haneke, E | 1 |
| Lecha, M | 1 |
| Ingber, A | 1 |
| Adamski, Z; Dworacki, G; Maleszka, R | 1 |
| Billstein, S; Evans, EG; Olafsson, JH; Paul, C; Sigurgeirsson, B; Steinsson, JB | 1 |
| Cao, C; Wen, H; Yan, L; Zhong, Y | 1 |
| Akar, A; Arca, E; Gür, AR; Kurumlu, Z; Taştan, HB | 1 |
| Guevara-Gutiérrez, E; Mayorga, J; Salazar-Páramo, M; Tlacuilo-Parra, A | 1 |
| Fukuda, T | 1 |
| Bell-Syer, SE; Brunt, E; Crawford, F; Godfrey, C; Hart, R; Russell, I; Young, P | 1 |
| Boissel, JP; Cribier, BJ; Haugh, M; Helou, S | 1 |
| Cauwenbergh, G; De Doncker, P; Heykants, J; Roseeuw, D; Van Cutsem, J; Van de Velde, V; Willems, J; Willemsen, M; Woestenborghs, R | 1 |
| Baran, R | 1 |
| Blomqvist, K; Brandt, H; Havu, V; Hollmen, A; Kohtamäki, K; Lehtonen, L; Piepponen, T; Turjanmaa, K | 1 |
| Arenas, R; Domínguez, L; Fernández, G | 1 |
| Cauwenbergh, G; De Doncker, P; Dockx, P; Janssen, PA; Matthieu, L; van de Velde, V; Woestenborghs, R | 1 |
| Stangerup, M; Svejgaard, E; Walsøe, I | 1 |
| Clayton, YM; Hay, RJ; Midgely, G; Moore, MK | 1 |
88 review(s) available for itraconazole and Onychomycosis
| Article | Year |
|---|---|
Review of the alternative therapies for onychomycosis and superficial fungal infections: posaconazole, fosravuconazole, voriconazole, oteseconazole.
Topics: Antifungal Agents; Complementary Therapies; Dermatologic Agents; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome; Voriconazole | 2022 |
Relative impact of traditional vs. newer oral antifungals for dermatophyte toenail onychomycosis: a network meta-analysis study.
Topics: Adult; Antifungal Agents; Arthrodermataceae; Bayes Theorem; Foot Dermatoses; Humans; Itraconazole; Nails; Naphthalenes; Network Meta-Analysis; Onychomycosis; Terbinafine; Treatment Outcome | 2023 |
The efficacy and safety of pulse vs. continuous therapy for dermatophyte toenail onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Humans; Itraconazole; Onychomycosis; Terbinafine; Treatment Outcome | 2020 |
Oral antifungal therapies for toenail onychomycosis: a systematic review with network meta-analysis toenail mycosis: network meta-analysis.
Topics: Antifungal Agents; Foot Dermatoses; Humans; Itraconazole; Nails; Network Meta-Analysis; Onychomycosis; Quality of Life; Treatment Outcome | 2022 |
Onychomycosis: a review.
Topics: Administration, Topical; Antifungal Agents; Fluconazole; Humans; Itraconazole; Onychomycosis; Terbinafine | 2020 |
A Timeline of Onychomycosis Therapy and Future Directions.
Topics: Administration, Topical; Antifungal Agents; Humans; Itraconazole; Nail Diseases; Onychomycosis; Terbinafine; Triazoles | 2020 |
Nondermatophyte mould onychomycosis.
Topics: Antifungal Agents; Humans; Itraconazole; Onychomycosis; Onygenales; Terbinafine | 2021 |
Onychomycosis: Treatment and prevention of recurrence.
Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Fluconazole; Humans; Itraconazole; Laser Therapy; Nanoparticles; Onychomycosis; Photochemotherapy; Plasma Gases; Prognosis; Pulse Therapy, Drug; Risk Factors; Secondary Prevention; Severity of Illness Index; Terbinafine; Triazoles | 2019 |
Monotherapy for toenail onychomycosis: a systematic review and network meta-analysis.
Topics: Antifungal Agents; Foot Dermatoses; Humans; Itraconazole; Nails; Naphthalenes; Network Meta-Analysis; Onychomycosis; Treatment Outcome | 2020 |
Rhodotorula minuta as onychomycosis agent in a Chinese patient: first report and literature review.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Asian People; China; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Onychomycosis; Pyrimidines; Rhodotorula; Triazoles; Voriconazole | 2014 |
Oral therapy for onychomycosis: an evidence-based review.
Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2014 |
What is new in fungal pharmacotherapeutics?
Topics: Allylamine; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Education, Medical, Continuing; Humans; Imidazoles; Itraconazole; Onychomycosis; Tinea Pedis; Triazoles | 2014 |
Antifungal agents for onychomycosis: new treatment strategies to improve safety.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Chemical and Drug Induced Liver Injury; Ciclopirox; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Triazoles | 2016 |
Onychomycosis in children. A review.
Topics: Administration, Oral; Administration, Topical; Adolescent; Antifungal Agents; Child; Child, Preschool; Fluconazole; Humans; Infant; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2017 |
Efficacy and tolerability of amorolfine 5% nail lacquer in combination with systemic antifungal agents for onychomycosis: A meta-analysis and systematic review.
Topics: Administration, Topical; Antifungal Agents; Drug Therapy, Combination; Humans; Itraconazole; Lacquer; Morpholines; Naphthalenes; Onychomycosis; Terbinafine | 2017 |
Clinical practice. Fungal nail disease.
Topics: Administration, Oral; Administration, Topical; Aged; Antifungal Agents; Ciclopirox; Debridement; Diagnosis, Differential; Foot Dermatoses; Humans; Itraconazole; Male; Naphthalenes; Onychomycosis; Practice Guidelines as Topic; Pyridones; Terbinafine | 2009 |
Fungal toenail infections.
Topics: Administration, Oral; Administration, Topical; Debridement; Foot Diseases; Humans; Itraconazole; Nails; Onychomycosis | 2008 |
Toenail onychomycosis in diabetic patients: issues and management.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Ciclopirox; Comorbidity; Diabetes Mellitus; Diabetic Foot; Drug Interactions; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Pyridones; Risk Factors; Terbinafine; Therapies, Investigational; Treatment Outcome | 2009 |
Efficacy of fluconazole for the treatment of onychomycosis.
Topics: Antifungal Agents; Arthrodermataceae; Clinical Trials as Topic; Dose-Response Relationship, Drug; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 2009 |
Onychomycosis.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2010 |
[Tinea unguium].
Topics: Aged; Antifungal Agents; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2011 |
A meta-analysis comparing long-term recurrences of toenail onychomycosis after successful treatment with terbinafine versus itraconazole.
Topics: Antifungal Agents; Drug Administration Schedule; Humans; Itraconazole; Middle Aged; Naphthalenes; Onychomycosis; Recurrence; Terbinafine; Treatment Outcome | 2012 |
Fungal toenail infections.
Topics: Administration, Oral; Administration, Topical; Debridement; Humans; Itraconazole; Nails; Onychomycosis | 2011 |
Onychomycosis: modern diagnostic and treatment approaches.
Topics: Antifungal Agents; Candidiasis; Combined Modality Therapy; Dermatomycoses; DNA, Fungal; Enzyme-Linked Immunosorbent Assay; Fluconazole; Humans; Itraconazole; Lasers, Solid-State; Low-Level Light Therapy; Naphthalenes; Onychomycosis; Opportunistic Infections; Polymerase Chain Reaction; Risk Factors; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Terbinafine; Tinea | 2013 |
Terbinafine: a review of its use in onychomycosis in adults.
Topics: Antifungal Agents; Arthrodermataceae; Diabetes Complications; Humans; Immunocompromised Host; Itraconazole; Mitosporic Fungi; Naphthalenes; Onychomycosis; Terbinafine; Yeasts | 2003 |
Onychomycosis: strategies to improve efficacy and reduce recurrence.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Biological Availability; Drug Interactions; Drug Therapy, Combination; Humans; Itraconazole; Naphthalenes; Onychomycosis; Recurrence; Terbinafine | 2002 |
Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails.
Topics: Adult; Antifungal Agents; Ciclopirox; Cost-Benefit Analysis; Drug Costs; Economics, Pharmaceutical; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Managed Care Programs; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; United States | 2003 |
Itraconazole versus terbinafine in the management of onychomycosis: an overview.
Topics: Antifungal Agents; Drug Administration Schedule; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2003 |
The use of oral antifungal agents to treat onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Drug Interactions; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2003 |
Efficacy and safety of itraconazole use in children.
Topics: Administration, Oral; Antifungal Agents; Capsules; Child; Child Welfare; Drug Administration Schedule; Drug Interactions; Humans; Itraconazole; Onychomycosis; Tinea Capitis | 2003 |
Cutaneous infections in the elderly: diagnosis and management.
Topics: 2-Aminopurine; Acetamides; Acyclovir; Aged; Anti-Bacterial Agents; Antidepressive Agents, Tricyclic; Antiviral Agents; Famciclovir; Herpes Zoster; Humans; Itraconazole; Linezolid; Onychomycosis; Oxazolidinones; Skin Diseases, Infectious; Virginiamycin | 2003 |
Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Randomized Controlled Trials as Topic; Terbinafine; Treatment Outcome | 2004 |
Assessing treatment outcomes in toenail onychomycosis clinical trials.
Topics: Antifungal Agents; Ciclopirox; Clinical Trials as Topic; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Treatment Outcome | 2004 |
Curing onychomycosis: understanding the multitude of variables.
Topics: Antifungal Agents; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2004 |
The systemic treatment of onychomycosis.
Topics: Antifungal Agents; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2004 |
The oral antifungal patient.
Topics: Administration, Oral; Antifungal Agents; Contraindications; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Patient Selection; Recurrence; Terbinafine | 2004 |
[Long QT interval. Interaction of terfenadine and itraconazole].
Topics: Antifungal Agents; Histamine H1 Antagonists; Humans; Itraconazole; Long QT Syndrome; Onychomycosis; Rhinitis, Allergic, Seasonal; Terfenadine | 2006 |
Fungal nail infections.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2005 |
A case of melanonychia due to Candida albicans.
Topics: Antifungal Agents; Candida albicans; Hand Dermatoses; Humans; Itraconazole; Male; Melanosis; Onychomycosis; Treatment Outcome | 2006 |
[Onychomycosis: recent progress in the epidemiology, diagnosis and treatment].
Topics: Administration, Topical; Antifungal Agents; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Risk Factors; Terbinafine | 2006 |
Fungal toenail infections.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2006 |
The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis.
Topics: Antifungal Agents; Dermatomycoses; Fluconazole; Humans; Itraconazole; Liver Function Tests; Models, Statistical; Naphthalenes; Onychomycosis; Pulse Therapy, Drug; Risk Assessment; Terbinafine; Transaminases | 2007 |
A case of onychomycosis due to Aspergillus sydowii diagnosed using DNA sequence analysis.
Topics: Adult; Antifungal Agents; Aspergillus; DNA, Fungal; Female; Foot Dermatoses; Humans; Itraconazole; Microscopy; Naphthalenes; Onychomycosis; Phylogeny; Pulse Therapy, Drug; Sequence Analysis, DNA; Terbinafine; Treatment Failure | 2008 |
Treatment of onychomycosis caused by dermatophytes--an opinion proposed by Committee for Standardization of the Japanese Society for Medical Mycology 2007.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Arthrodermataceae; Dermatomycoses; Humans; Itraconazole; Japan; Mycology; Naphthalenes; Onychomycosis; Practice Guidelines as Topic; Societies, Medical; Terbinafine | 2008 |
The systemic treatment of onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 1995 |
Oral therapeutic agents in fungal nail disease.
Topics: Administration, Oral; Allylamine; Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine; Time Factors; Treatment Outcome | 1994 |
A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. The Onychomycosis Study Group.
Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Foot Dermatoses; Griseofulvin; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Models, Econometric; Naphthalenes; Onychomycosis; State Medicine; Terbinafine | 1994 |
Onychomycosis. Agents of choice.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Candidiasis, Cutaneous; Fluconazole; Foot Dermatoses; Griseofulvin; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 1993 |
New approaches to the treatment of onychomycosis.
Topics: Adult; Antifungal Agents; Humans; Itraconazole; Ketoconazole; Male; Naphthalenes; Onychomycosis; Terbinafine | 1993 |
[Oral antifungal drugs].
Topics: Administration, Oral; Antifungal Agents; Dermatomycoses; Drug Administration Schedule; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 1995 |
Treatment of onychomycosis and tinea pedis with intermittent itraconazole therapy.
Topics: Administration, Oral; Adult; Antifungal Agents; Drug Administration Schedule; Female; Foot Dermatoses; Humans; Itraconazole; Onychomycosis; Tinea Pedis | 1996 |
New antifungal therapy for children.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Child; Dermatomycoses; Drug Interactions; Fluconazole; Hair Diseases; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
Onychomycosis--treatment, relapse and re-infection.
Topics: Antifungal Agents; Clinical Trials as Topic; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Prognosis; Recurrence; Terbinafine | 1997 |
Current trends in onychomycosis therapy: a literature review.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
Oral treatment options for onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Drug Interactions; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview.
Topics: Antifungal Agents; Dermatomycoses; Drug Administration Schedule; Drug Monitoring; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Onychomycosis; Remission Induction; Safety; Tinea; Tinea Pedis | 1997 |
[Superficial mycoses in immunosuppressed patients].
Topics: Adult; Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Child; Dermatitis, Seborrheic; Dermatomycoses; Female; Fluconazole; Humans; Imidazoles; Immunosuppression Therapy; Itraconazole; Ketoconazole; Male; Morpholines; Onychomycosis; Tinea; Tinea Versicolor; Transplantation; Triazoles | 1995 |
Itraconazole for the treatment of onychomycosis.
Topics: Antifungal Agents; Dermatomycoses; Humans; Itraconazole; Onychomycosis; Treatment Outcome | 1998 |
Causative pathogens in onychomycosis and the possibility of treatment resistance: a review.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antifungal Agents; Arthrodermataceae; Candida; Drug Resistance, Microbial; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1998 |
Systemic antifungal agents used to treat onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Arthrodermataceae; Candida; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1998 |
Cost-effectiveness of two new treatments for onychomycosis: an analysis of two comparative clinical trials.
Topics: Antifungal Agents; Clinical Trials as Topic; Cost-Benefit Analysis; Decision Support Techniques; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1998 |
[Diagnosis, differential diagnosis and therapy of onychomycosis].
Topics: Administration, Topical; Antifungal Agents; Diagnosis, Differential; Drug Administration Schedule; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1998 |
Onychomycosis: pathogenesis, diagnosis, and management.
Topics: Adult; Antifungal Agents; Child; Diagnosis, Differential; Female; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Male; Nails; Naphthalenes; Onychomycosis; Terbinafine | 1998 |
Itraconazole pulse: an overview of current use.
Topics: Antifungal Agents; Humans; Itraconazole; Onychomycosis | 1998 |
How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data.
Topics: Antifungal Agents; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Recurrence; Remission Induction; Terbinafine | 1998 |
Current topics in diagnosis and treatment of tinea unguium in Japan.
Topics: Administration, Oral; Aged; Antifungal Agents; Diagnosis, Differential; Female; Fluconazole; Griseofulvin; Humans; Itraconazole; Japan; Male; Onychomycosis | 1999 |
Management of toenail onychomycosis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Clinical Trials as Topic; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Toes | 1999 |
Itraconazole and terbinafine in perspective. From petri dish to patient.
Topics: Administration, Oral; Animals; Antifungal Agents; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Tinea Pedis | 1999 |
Onychomycosis in diabetes. Management considerations.
Topics: Antifungal Agents; Diabetes Complications; Drug Interactions; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1999 |
Management of onychomycosis in children.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Naphthalenes; North America; Onychomycosis; Prevalence; Recurrence; Terbinafine | 1999 |
Oral itraconazole therapy for superficial, subcutaneous, and systemic infections. A panoramic view.
Topics: Administration, Oral; Antifungal Agents; Dermatomycoses; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Mycoses; Onychomycosis | 1999 |
Itraconazole and terbinafine in perspective: from petri dish to patient.
Topics: Animals; Antifungal Agents; Clinical Trials as Topic; Foot Dermatoses; Humans; In Vitro Techniques; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Tinea Pedis | 1999 |
Facing up to the diagnostic uncertainty and management of onychomycoses.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1999 |
The use of intermittent itraconazole therapy for superficial mycotic infections: a review and update on the 'one week' approach.
Topics: Antifungal Agents; Dermatomycoses; Drug Administration Schedule; Humans; Itraconazole; Onychomycosis; Time Factors; Treatment Outcome | 1999 |
Pharmacoeconomic analysis of the new oral antifungal agents used to treat toenail onychomycosis in the USA.
Topics: Administration, Oral; Antifungal Agents; Cost-Benefit Analysis; Drug Costs; Economics, Pharmaceutical; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; United States | 1999 |
The new oral antifungal agents for onychomycosis of the toenails.
Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Male; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1999 |
Onychomycosis: treatment perspective.
Topics: Antifungal Agents; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2000 |
An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents.
Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Dermatomycoses; Drug Administration Schedule; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2000 |
Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Arthrodermataceae; Ciclopirox; Costs and Cost Analysis; Drug Costs; Economics, Pharmaceutical; Female; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Male; Models, Economic; Naphthalenes; Onychomycosis; Pyridones; Randomized Controlled Trials as Topic; Terbinafine; United States | 2000 |
Current management of fungal infections.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Dermatomycoses; Fluconazole; Humans; Intestinal Absorption; Itraconazole; Onychomycosis | 2001 |
Treating onychomycosis.
Topics: Adult; Antifungal Agents; Child; Clinical Trials as Topic; Combined Modality Therapy; Diagnosis, Differential; Drug Costs; Drug Interactions; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Patient Education as Topic; Recurrence; Teaching Materials; Terbinafine; Treatment Failure | 2001 |
Itraconazole: an effective oral antifungal for onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Arthrodermataceae; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; Itraconazole; Onychomycosis | 2001 |
A plea to bridge the gap between antifungals and the management of onychomycosis.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2001 |
The future of onychomycosis therapy may involve a combination of approaches.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Combined Modality Therapy; Drug Therapy, Combination; Griseofulvin; Humans; Itraconazole; Nails; Naphthalenes; Onychomycosis; Patient Satisfaction; Prevalence; Quality of Life; Terbinafine; Treatment Failure | 2001 |
The rationale for combination therapy.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Arthrodermataceae; Cell Wall; Drug Therapy, Combination; Ergosterol; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Recurrence; Terbinafine | 2001 |
Treatment of dermatophyte toenail onychomycosis in the United States. A pharmacoeconomic analysis.
Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Drug Costs; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; United States | 2002 |
Oral treatments for toenail onychomycosis: a systematic review.
Topics: Administration, Oral; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Evidence-Based Medicine; Female; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Ketoconazole; Male; Naphthalenes; Onychomycosis; Prognosis; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Terbinafine; Treatment Outcome | 2002 |
Terbinafine in fungal infections of the nails: a meta-analysis of randomized clinical trials.
Topics: Antifungal Agents; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Randomized Controlled Trials as Topic; Terbinafine | 2002 |
78 trial(s) available for itraconazole and Onychomycosis
| Article | Year |
|---|---|
Comparative study of safety and efficacy of combination therapy of fractional CO
Topics: Antifungal Agents; Carbon Dioxide; Humans; Itraconazole; Lasers, Gas; Onychomycosis; Treatment Outcome | 2023 |
[Effect of 0.9-ms 1064-nm Nd:YAG laser combined with itraconazole for treatment of toenail onychomycosis].
Topics: Antifungal Agents; Humans; Itraconazole; Lasers, Solid-State; Nails; Onychomycosis; Treatment Outcome | 2018 |
An exploration of the optimum dosage and number of cycles of itraconazole pulse therapy for severe onychomycosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Outpatients; Prospective Studies; Treatment Outcome; Young Adult | 2018 |
Combined long-pulsed Nd-Yag laser and itraconazole versus itraconazole alone in the treatment of onychomycosis nails.
Topics: Adult; Antifungal Agents; Combined Modality Therapy; Female; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Lasers, Solid-State; Male; Middle Aged; Onychomycosis; Patient Satisfaction; Pulse Therapy, Drug; Treatment Outcome | 2020 |
Randomized, placebo-controlled, phase 3 study of itraconazole for the treatment of onychomycosis.
Topics: Adult; Antifungal Agents; Capsules; Drug Administration Schedule; Drug Delivery Systems; Female; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Single-Blind Method; Tablets; Treatment Outcome | 2013 |
Treatment of Onychomycosis - a Clinical Study.
Topics: Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pulse Therapy, Drug; Pyridones; Terbinafine | 2015 |
Randomized, double-blind, comparative study on efficacy and safety of itraconazole pulse therapy and terbinafine pulse therapy on nondermatophyte mold onychomycosis: A study with 90 patients.
Topics: Adult; Antifungal Agents; Double-Blind Method; Female; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 2016 |
Self-controlled Study of Onychomycosis Treated with Long-pulsed Nd:YAG 1064-nm Laser Combined with Itraconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Combined Modality Therapy; Female; Humans; Itraconazole; Laser Therapy; Lasers, Solid-State; Male; Middle Aged; Onychomycosis; Treatment Outcome; Young Adult | 2016 |
4beta-hydroxycholesterol as a marker of CYP3A4 inhibition in vivo - effects of itraconazole in man.
Topics: Antifungal Agents; Biomarkers, Pharmacological; Cholesterol; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Humans; Hydroxycholesterols; Itraconazole; Male; Onychomycosis | 2009 |
Histopathological periodic acid-schiff stains of nail clippings as a second-line diagnostic tool in onychomycosis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Female; Fungi; Glycogen; Humans; Itraconazole; Male; Middle Aged; Mycology; Nails; Naphthalenes; Onychomycosis; Periodic Acid-Schiff Reaction; Terbinafine; Treatment Outcome; Young Adult | 2012 |
Prognostic factors of mycological cure following treatment of onychomycosis with oral antifungal agents.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antifungal Agents; Double-Blind Method; Female; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Logistic Models; Male; Middle Aged; Onychomycosis; Prognosis; Treatment Outcome | 2002 |
Itraconazole pulse therapy improves the quality of life of patients with toenail onychomycosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Drug Administration Schedule; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Pulse Therapy, Drug; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2003 |
A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Antifungal Agents; Candidiasis; Drug Administration Schedule; Drug Therapy, Combination; Female; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Morpholines; Onychomycosis; Prospective Studies; Treatment Outcome | 2003 |
Itraconazole pulse therapy in the treatment of disto-lateral subungual onychomycosis.
Topics: Adult; Antifungal Agents; Drug Administration Schedule; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Maximum Tolerated Dose; Middle Aged; Onychomycosis; Prospective Studies; Pulse Therapy, Drug; Severity of Illness Index; Single-Blind Method; Treatment Outcome | 2003 |
[Optimal dosages and cycles of itraconazole pulse therapy for onychomycosis].
Topics: Antifungal Agents; Double-Blind Method; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Onychomycosis; Pulse Therapy, Drug | 2004 |
[Assessment of mycological and clinical factors on the course and results of treatment of mycotic infections in patients with recurrent onychomycosis].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Epidermophyton; Humans; Itraconazole; Middle Aged; Morpholines; Nails; Naphthalenes; Onychomycosis; Pentoxifylline; Recurrence; Terbinafine; Treatment Outcome; Trichophyton | 2003 |
A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Dose-Response Relationship, Drug; Female; Foot Dermatoses; Gastrointestinal Diseases; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Onychomycosis; Patient Dropouts; Pilot Projects; Pruritus; Species Specificity; Terbinafine; Treatment Outcome | 2005 |
Study of oral itraconazole and terbinafine pulse therapy in onychomycosis.
Topics: Adolescent; Adult; Antifungal Agents; Chi-Square Distribution; Female; Humans; Itraconazole; Male; Middle Aged; Nails; Naphthalenes; Onychomycosis; Terbinafine; Time Factors; Treatment Outcome | 2006 |
[Study on the compliance and safety of the oral antifungal agents for the treatment of onychomycosis].
Topics: Administration, Oral; Age Factors; Antifungal Agents; Dose-Response Relationship, Drug; Female; Humans; Itraconazole; Male; Naphthalenes; Onychomycosis; Patient Compliance; Surveys and Questionnaires; Terbinafine | 2005 |
Two novel itraconazole pulse therapies for onychomycosis: a 2-year follow-up.
Topics: Administration, Oral; Antifungal Agents; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Onychomycosis; Pulse Therapy, Drug; Severity of Illness Index; Treatment Outcome | 2006 |
Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
Topics: Antifungal Agents; Diabetes Complications; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Prospective Studies; Pulse Therapy, Drug; Terbinafine; Treatment Outcome | 2006 |
Effects of high-dose itraconazole treatment on lipoproteins in men.
Topics: Antifungal Agents; Apolipoprotein A-I; Caco-2 Cells; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Triglycerides | 2007 |
Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat?
Topics: Adult; Antifungal Agents; Chronic Disease; Female; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Leg; Male; Middle Aged; Nails; Onychomycosis; Prevalence; Treatment Outcome; Venous Insufficiency | 2008 |
Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group.
Topics: Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1995 |
Open randomized comparison of itraconazole versus terbinafine in onychomycosis.
Topics: Adult; Antifungal Agents; Drug Administration Schedule; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Prospective Studies; Terbinafine; Treatment Outcome | 1995 |
Treatment of tinea unguium with medium and high doses of ultramicrosize griseofulvin compared with that with itraconazole.
Topics: Adult; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Female; Griseofulvin; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Particle Size; Patient Compliance | 1993 |
Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole.
Topics: Aged; Analysis of Variance; Antifungal Agents; Chi-Square Distribution; Drug Administration Schedule; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Nails; Onychomycosis; Trichophyton | 1996 |
Pulse therapy with one-week itraconazole monthly for three or four months in the treatment of onychomycosis.
Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Treatment Outcome | 1995 |
Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy.
Topics: Administration, Oral; Adult; Antifungal Agents; Drug Administration Schedule; Drug Tolerance; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine | 1996 |
Antifungal pulse therapy for onychomycosis.
Topics: Antifungal Agents; Foot Dermatoses; HIV Reverse Transcriptase; Humans; Itraconazole; Onychomycosis; RNA-Directed DNA Polymerase; Treatment Outcome | 1996 |
A double-blind, randomized comparison of itraconazole capsules and placebo in the treatment of onychomycosis of the toenail.
Topics: Adult; Aged; Antifungal Agents; Capsules; Double-Blind Method; Female; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Placebos; Remission Induction | 1996 |
A 12-week treatment for dermatophyte toe onychomycosis: terbinafine 250 mg/day vs. itraconazole 200 mg/day--a double-blind comparative trial.
Topics: Administration, Oral; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1996 |
German randomized double-blind multicentre comparison of terbinafine and itraconazole for the treatment of toenail tinea infection.
Topics: Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Patient Satisfaction; Terbinafine; Tinea Pedis | 1996 |
Paradoxical response to itraconazole treatment in a patient with onychomycosis caused by Microsporum gypseum.
Topics: Administration, Oral; Adult; Biological Availability; Humans; Intestinal Absorption; Itraconazole; Male; Microsporum; Onychomycosis | 1995 |
Double-blind, randomized comparison of itraconazole capsules and placebo in onychomycosis of toenail.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Capsules; Diarrhea; Double-Blind Method; Female; Follow-Up Studies; Foot Dermatoses; Headache; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Placebos; Remission Induction; Rhinitis; Sinusitis; Trichophyton | 1996 |
Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: a multicenter study with 36 patients.
Topics: Antifungal Agents; Drug Administration Schedule; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Onychomycosis; Treatment Outcome | 1997 |
A multicenter, placebo-controlled, double-blind study of intermittent therapy with itraconazole for the treatment of onychomycosis of the fingernail.
Topics: Adult; Aged; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Drug Eruptions; Female; Gastrointestinal Diseases; Hand Dermatoses; Headache; Humans; Hypertriglyceridemia; Itraconazole; Male; Middle Aged; Onychomycosis; Pruritus; Treatment Outcome | 1997 |
A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis.
Topics: Adolescent; Adult; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Treatment Outcome | 1997 |
Itraconazole in onychomycosis: intermittent dose schedule.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Drug Administration Schedule; Female; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis | 1997 |
Double-blind, randomized comparison of itraconazole capsules vs. placebo in the treatment of toenail onychomycosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Placebos; Treatment Outcome | 1997 |
Small-dose itraconazole pulse therapy in the treatment of onychomycosis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Treatment Outcome | 1997 |
Terbinafine versus itraconazole: a controlled clinical comparison in onychomycosis of the toenails.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome; Trichophyton | 1998 |
Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Arthrodermataceae; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1998 |
Itraconazole in the treatment of onychomycosis: a double-blind comparison with miconazole.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Foot Dermatoses; Germany; Hand Dermatoses; Humans; Itraconazole; Male; Miconazole; Middle Aged; Onychomycosis; Treatment Outcome | 1998 |
Successful treatment of toenail mycosis with terbinafine and itraconazole gives long term benefits.
Topics: Antifungal Agents; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1998 |
Efficacy and safety of itraconazole pulse therapy: Brazilian multicentric study on toenail onychomycosis caused by dermatophytes.
Topics: Abdominal Pain; Adult; Aged; Antifungal Agents; Arthrodermataceae; Brazil; Candida; Data Interpretation, Statistical; Dermatomycoses; Drug Administration Schedule; Female; Follow-Up Studies; Headache; Humans; Itraconazole; Male; Microsporum; Middle Aged; Nausea; Onychomycosis; Patient Dropouts; Prospective Studies; Toes; Treatment Outcome; Trichophyton | 1998 |
Safety and efficacy of intermittent therapy with itraconazole in finger- and toenail onychomycosis: a multicentre trial.
Topics: Adult; Antifungal Agents; Female; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Treatment Outcome | 1998 |
[Evaluation of the efficacy of small-dose itraconazole pulse therapy (200 mg/day) for tinea unguium].
Topics: Adult; Aged; Drug Evaluation; Female; Humans; Itraconazole; Male; Middle Aged; Onychomycosis | 1999 |
Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Prospective Studies; Terbinafine; Treatment Outcome | 1999 |
Continuous and intermittent itraconazole dosing schedules for the treatment of onychomycosis: a pharmacokinetic comparison.
Topics: Adolescent; Adult; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Female; Humans; Itraconazole; Male; Middle Aged; Onychomycosis | 1999 |
Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis.
Topics: Abdominal Pain; Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Dyspepsia; Female; Foot Dermatoses; Headache; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Nausea; Onychomycosis; Taste Disorders; Terbinafine; Treatment Outcome; Trichophyton; Virus Diseases | 1999 |
Clinical and pharmacokinetic investigations of oral intraconazole in the treatment of onychomycosis.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Female; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Treatment Outcome | 1999 |
A comparison among four regimens of itraconazole treatment in onychomycosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Drug Administration Schedule; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Middle Aged; Onychomycosis; Treatment Outcome | 1999 |
The safety of itraconazole in the diabetic population.
Topics: Administration, Oral; Aged; Antifungal Agents; Diabetes Complications; Female; Foot Dermatoses; Humans; Itraconazole; Male; Onychomycosis; Palliative Care | 1999 |
Therapeutic efficacy and safety of one-week intermittent therapy with itraconazole for onychomycosis in a Chinese patient population.
Topics: Adolescent; Adult; Aged; Anorexia; Antifungal Agents; Candida; China; Drug Administration Schedule; Female; Gastrointestinal Diseases; Humans; Itraconazole; Male; Middle Aged; Nausea; Onychomycosis; Time Factors; Treatment Outcome; Trichophyton; Xerostomia | 1999 |
Itraconazole pulse therapy vs continuous terbinafine dosing for toenail onychomycosis.
Topics: Antifungal Agents; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1999 |
The use of itraconazole to treat cutaneous fungal infections in children.
Topics: Antifungal Agents; Child; Child, Preschool; Dermatomycoses; Dose-Response Relationship, Drug; Drug Eruptions; Follow-Up Studies; Foot Dermatoses; Gastritis; Headache; Humans; Infant; Itraconazole; Microsporum; Onychomycosis; Patient Dropouts; Skin; Time Factors; Tinea; Tinea Capitis; Tinea Pedis; Treatment Outcome; Trichophyton | 1999 |
L.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Prospective Studies; Terbinafine; Treatment Outcome | 1999 |
Long-term outcomes in the treatment of toenail onychomycosis.
Topics: Antifungal Agents; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1999 |
The boosted oral antifungal treatment for onychomycosis beyond the regular itraconazole pulse dosing regimen.
Topics: Administration, Oral; Antifungal Agents; Chronic Disease; Humans; Itraconazole; Nails; Onychomycosis; Pilot Projects; Trichophyton | 2000 |
Itraconazole pulse therapy for dermatophyte onychomycosis in children.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Onychomycosis; Retrospective Studies; Time Factors; Treatment Outcome | 2000 |
Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Onychomycosis; Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique; Terbinafine; Trichophyton | 1999 |
Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
Topics: Age Factors; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Patient Compliance; Prospective Studies; Single-Blind Method; Terbinafine; Treatment Outcome | 2001 |
Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
Topics: Adult; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Prospective Studies; Single-Blind Method; Terbinafine; Treatment Outcome | 2001 |
Continuous terbinafine or pulse itraconazole: a comparative study on onychomycosis.
Topics: Adult; Antifungal Agents; Female; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine | 2000 |
Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: an analysis of based on results from the L.I.ON. study. Lamisil versus Itraconazole in Onychomycosis.
Topics: Antifungal Agents; Cost-Benefit Analysis; Foot Dermatoses; Humans; Itraconazole; Multicenter Studies as Topic; Naphthalenes; Onychomycosis; Randomized Controlled Trials as Topic; Terbinafine | 2001 |
Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Follow-Up Studies; Foot Dermatoses; Gastrointestinal Diseases; Griseofulvin; Humans; Itraconazole; Male; Middle Aged; Mitosporic Fungi; Naphthalenes; Nausea; Onychomycosis; Photosensitivity Disorders; Prospective Studies; Single-Blind Method; Terbinafine; Treatment Outcome; Vomiting | 2001 |
One week pulse therapy with itraconazole (200 mg day-1) for onychomycosis. Evaluation of treatment results according to patient background.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Itraconazole; Longitudinal Studies; Male; Middle Aged; Occupations; Onychomycosis; Pulse Therapy, Drug; Time Factors; Treatment Outcome | 2001 |
Age as limiting factor of the efficacy of itraconazole for treatment of onychomycosis.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Antifungal Agents; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Treatment Outcome | 2001 |
Itraconazole pulse therapy for the treatment of Candida onychomycosis.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Pulse Therapy, Drug; Treatment Outcome | 2001 |
Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Drug Costs; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Morpholines; Onychomycosis; Treatment Outcome; Trichophyton | 2001 |
Evaluation of lymphocytes subpopulations and natural killer cells in peripheral blood of patients treated for dermatophyte onychomycosis.
Topics: Antifungal Agents; Antigens, CD19; CD3 Complex; CD4 Antigens; Epidermophyton; Foot Dermatoses; Hand Dermatoses; HLA-DR Antigens; Humans; Itraconazole; Killer Cells, Natural; Lymphocyte Count; Lymphocyte Subsets; Naphthalenes; Onychomycosis; Salicylates; Terbinafine; Trichophyton | 2001 |
Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study.
Topics: Adult; Aged; Antifungal Agents; Double-Blind Method; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Longitudinal Studies; Middle Aged; Naphthalenes; Onychomycosis; Prospective Studies; Recurrence; Retreatment; Terbinafine; Tinea; Treatment Outcome; Trichophyton | 2002 |
Long-term results in patients with onychomycosis treated with terbinafine or itraconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 2002 |
An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Female; Fluconazole; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine | 2002 |
Efficacy and safety of itraconazole in the long-term treatment of onychomycosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Arthrodermataceae; Dermatomycoses; Drug Administration Schedule; Female; Griseofulvin; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Onychomycosis; Single-Blind Method | 1992 |
Onychomycosis treated with itraconazole or griseofulvin alone with and without a topical antimycotic or keratolytic agent.
Topics: Administration, Topical; Adult; Antifungal Agents; Drug Therapy, Combination; Emollients; Female; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Keratolytic Agents; Ketoconazole; Male; Middle Aged; Onychomycosis; Prospective Studies | 1991 |
Itraconazole in onychomycosis. Open and double-blind studies.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Double-Blind Method; Female; Follow-Up Studies; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Onychomycosis; Random Allocation; Recurrence | 1990 |
159 other study(ies) available for itraconazole and Onychomycosis
| Article | Year |
|---|---|
Analysis of utilization, cost and, prescription trends of onychomycosis medications among Medicare patients.
Topics: Administration, Topical; Aged; Antifungal Agents; Humans; Itraconazole; Medicare; Onychomycosis; Prescriptions; Terbinafine; United States | 2022 |
Onychomycosis in Older Adults: Prevalence, Diagnosis, and Management.
Topics: Administration, Topical; Aged; Antifungal Agents; Female; Humans; Itraconazole; Male; Onychomycosis; Prevalence | 2022 |
Acitretin: Could it be a new therapeutic player in the field of onychomycosis?
Topics: Acitretin; Adult; Antifungal Agents; Foot Dermatoses; Humans; Itraconazole; Onychomycosis; Treatment Outcome | 2022 |
A deletion mutation in the amino acid sequence of squalene epoxidase in terbinafine-resistant Trichophytonrubrum.
Topics: Amino Acid Sequence; Antifungal Agents; Drug Resistance, Fungal; Humans; Itraconazole; Microbial Sensitivity Tests; Onychomycosis; Sequence Deletion; Squalene Monooxygenase; Terbinafine; Trichophyton | 2022 |
Distinct patient characteristics and pathogenesis of fingernail only vs. fingernail and toenail onychomycosis in a retrospective single-centre academic study.
Topics: Antifungal Agents; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Nails; Onychomycosis; Retrospective Studies | 2023 |
Q-switched Nd:YAG laser versus itraconazole pulse therapy in treatment of onychomycosis: A clinical dermoscopic and mycologic study.
Topics: Antifungal Agents; Humans; Itraconazole; Lasers, Solid-State; Onychomycosis; Prospective Studies; Treatment Outcome | 2023 |
Review of treatments for toenail onychomycosis caused by dermatophytes.
Topics: Antifungal Agents; Arthrodermataceae; Foot Dermatoses; Humans; Itraconazole; Nails; Onychomycosis | 2023 |
Comparing the Efficacy for Pulse Versus Continuous Dose Terbinafine Therapy in Patients With Onychomycosis.
Topics: Antifungal Agents; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 2023 |
Continuous terbinafine and pulse itraconazole for the treatment of non-dermatophyte mold toenail onychomycosis.
Topics: Administration, Oral; Adult; Antifungal Agents; Atherosclerosis; Female; Humans; Hyperlipidemias; Itraconazole; Logistic Models; Male; Middle Aged; Nails; Onychomycosis; Retrospective Studies; Severity of Illness Index; Terbinafine; Treatment Outcome | 2021 |
Prognostic factors influencing the treatment outcome of onychomycosis Candida.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Child; Female; Humans; Itraconazole; Middle Aged; Nail Diseases; Nails; Onychomycosis; Prognosis; Retrospective Studies; Treatment Outcome; Young Adult | 2020 |
Retrospective analysis of adverse events with systemic onychomycosis medications reported to the United States Food and Drug Administration.
Topics: Administration, Oral; Antifungal Agents; Child; Humans; Itraconazole; Naphthalenes; Onychomycosis; Retrospective Studies; United States; United States Food and Drug Administration | 2021 |
Effect of monoterpenes on ex vivo transungual delivery of itraconazole for the management of onychomycosis.
Topics: Administration, Topical; Humans; Itraconazole; Monoterpenes; Nails; Onychomycosis | 2020 |
In vitro antifungal susceptibility testing of fungi in patients with onychomycosis.
Topics: Antifungal Agents; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2020 |
Successful treatment of resistant onychomycosis with voriconazole in a liver transplant patient.
Topics: Antifungal Agents; Humans; Itraconazole; Liver Transplantation; Onychomycosis; Terbinafine; Voriconazole | 2020 |
Onychomycosis Due to Arthrinium arundinis: A Case Report.
Topics: Adult; Antifungal Agents; Ascomycota; Drug Therapy, Combination; Foot Dermatoses; Humans; Itraconazole; Male; Microscopy, Electron, Scanning; Morpholines; Onychomycosis; Remission Induction; Treatment Outcome | 2017 |
Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis.
Topics: Amphotericin B; Antifungal Agents; Female; Fluconazole; Fusariosis; Fusarium; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Nails; Naphthalenes; Onychomycosis; Terbinafine; Voriconazole | 2017 |
Topical antifungal treatment prevents recurrence of toenail onychomycosis following cure.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Retrospective Studies; Secondary Prevention; Terbinafine | 2017 |
Risk of Psoriasis Following Terbinafine or Itraconazole Treatment for Onychomycosis: A Population-Based Case-Control Comparative Study.
Topics: Antifungal Agents; Case-Control Studies; Female; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Psoriasis; Risk; Taiwan; Terbinafine | 2018 |
The Energy Density and Treatment Times Are the Main Factors That Affect the Efficacy of Long-Pulsed 1,064-nm Nd:YAG Laser Treatment for Onychomycosis Caused by Trichophyton rubrum.
Topics: Adolescent; Adult; Antifungal Agents; Female; Foot Dermatoses; Humans; Itraconazole; Lasers, Solid-State; Low-Level Light Therapy; Male; Middle Aged; Onychomycosis; Treatment Outcome; Trichophyton; Young Adult | 2018 |
Ultrastructural changes of Trichophyton rubrum in tinea unguium after itraconazole therapy in vivo observed using scanning electron microscopy.
Topics: Antifungal Agents; Female; Humans; Itraconazole; Male; Microscopy, Electron, Scanning; Middle Aged; Onychomycosis; Trichophyton | 2018 |
Diversity of phenotypically non-dermatophyte, non-Aspergillus filamentous fungi causing nail infections: importance of accurate identification and antifungal susceptibility testing.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Biodiversity; Child; Child, Preschool; Female; Fluconazole; Fungi; Hong Kong; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Nail Diseases; Onychomycosis; Phenotype; Phylogeny; Terbinafine; Young Adult | 2019 |
First case of Tritirachium oryzae as agent of onychomycosis and its susceptibility to antifungal drugs.
Topics: Adult; Antifungal Agents; Basidiomycota; DNA, Fungal; DNA, Ribosomal Spacer; Female; Humans; Iran; Itraconazole; Microbial Sensitivity Tests; Microbiological Techniques; Microscopy; Molecular Sequence Data; Nails; Onychomycosis; Sequence Analysis, DNA; Triazoles | 2013 |
[Diagnosis of non dermatophyte onychomycosis ant its relevance for treatment].
Topics: Acremonium; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Fusariosis; Fusarium; Humans; Itraconazole; Naphthalenes; Onychomycosis; Polymerase Chain Reaction; Reproducibility of Results; Terbinafine | 2013 |
Nail psoriasis masqueraded by secondary infection with Rhodotorula mucilaginosa.
Topics: Acitretin; Adult; Anti-Inflammatory Agents; Antifungal Agents; Betamethasone; Calcitriol; Coinfection; Dermatologic Agents; Humans; Itraconazole; Keratolytic Agents; Male; Microbiological Techniques; Molecular Diagnostic Techniques; Nails; Onychomycosis; Psoriasis; Rhodotorula; Treatment Outcome | 2013 |
[Photo quiz: Dermatomycosis].
Topics: Administration, Oral; Antifungal Agents; Candida albicans; Candidiasis, Cutaneous; Diagnostic Errors; Female; Foot Dermatoses; Humans; Itraconazole; Microscopy; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Failure; Treatment Outcome | 2013 |
Longitudinal monitoring of CYP3A activity in patients receiving 3 cycles of itraconazole pulse therapy for onychomycosis.
Topics: Adult; Aged; Antifungal Agents; Cytochrome P-450 CYP3A Inhibitors; Drug Monitoring; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Hydrocortisone; Itraconazole; Longitudinal Studies; Male; Middle Aged; Onychomycosis; Pulse Therapy, Drug; Time Factors; Treatment Outcome | 2014 |
Oral terbinafine and itraconazole treatments against dermatophytes appear not to favor the establishment of Fusarium spp. in nail.
Topics: Administration, Oral; Adult; Arthrodermataceae; Cohort Studies; DNA, Fungal; Drug Therapy, Combination; Female; Fusarium; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Polymerase Chain Reaction; Retrospective Studies; Severity of Illness Index; Terbinafine; Treatment Failure; Trichophyton | 2014 |
Design and development of a safer non-invasive transungual drug delivery system for topical treatment of onychomycosis.
Topics: Administration, Topical; Antifungal Agents; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Liberation; Emulsions; Excipients; Gels; Humans; Itraconazole; Nails; Onychomycosis; Particle Size; Permeability; Surface-Active Agents; Urea | 2015 |
Fungal melanonychia caused by Trichophyton rubrum and the value of dermoscopy.
Topics: Administration, Cutaneous; Adult; Antifungal Agents; Dermoscopy; Diagnosis, Differential; Foot Dermatoses; Humans; Itraconazole; Male; Onychomycosis; Pigmentation; Trichophyton | 2014 |
Fusarium onychomycosis: prevalence, clinical presentations, response to itraconazole and terbinafine pulse therapy, and 1-year follow-up in nine cases.
Topics: Adult; Aged; Antifungal Agents; Female; Foot Dermatoses; Fusariosis; Hand Dermatoses; Humans; Immunocompetence; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Paronychia; Recurrence; Terbinafine; Treatment Outcome | 2015 |
The First Case of Total Dystrophic Onychomycosis Caused by Aspergillus clavatus Resistant to Antifungal Drugs.
Topics: Adult; Antifungal Agents; Aspergillus; Base Sequence; Drug Resistance, Multiple, Fungal; Female; Hand Dermatoses; Humans; Itraconazole; Microbial Sensitivity Tests; Onychomycosis; Sequence Analysis, DNA; Tubulin | 2016 |
Onychomycosis caused by Trichosporon mucoides.
Topics: Aged; Humans; Itraconazole; Male; Onychomycosis; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Trichosporon | 2016 |
Onychomycosis: Strategies to Minimize Recurrence.
Topics: Administration, Topical; Antifungal Agents; Comorbidity; Diabetes Mellitus; Drug Administration Schedule; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Recurrence; Terbinafine; Tinea Pedis; Triazoles | 2016 |
Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Treatment Outcome; Triazoles; United States | 2016 |
A Case of Fingernail Onychomycosis due to Aspergillus flavus.
Topics: Aspergillus flavus; Female; Hand Dermatoses; Humans; Itraconazole; Middle Aged; Nails; Onychomycosis; Pulse Therapy, Drug; Treatment Outcome | 2016 |
Prevalence and epidemiology of tinea pedis and toenail onychomycosis and antifungal susceptibility of the causative agents in patients with type 2 diabetes in Turkey.
Topics: Adult; Age Factors; Aged; Antifungal Agents; Arthrodermataceae; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fluconazole; Glycated Hemoglobin; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Onychomycosis; Prevalence; Sex Factors; Terbinafine; Tinea Pedis; Toes; Trichophyton; Turkey | 2017 |
Factors influencing cure rates of non-dermatophyte mold and Candida onychomycosis: analysis of outcomes in 81 patients who completed treatment.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Candidiasis; Detergents; Diabetes Complications; Eczema; Female; Foot Dermatoses; Fusariosis; Hand Dermatoses; Humans; Hypertension; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Paronychia; Risk Factors; Soil; Terbinafine; Time-to-Treatment; Treatment Outcome; Water; Young Adult | 2017 |
Topical Antifungals for Treatment of Onychomycosis.
Topics: Administration, Topical; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials as Topic; Humans; Itraconazole; Onychomycosis; Remission Induction; Toes | 2016 |
Pseudo-onychomycosis.
Topics: Antifungal Agents; Female; Humans; Itraconazole; Middle Aged; Onychomycosis; Tinea; Treatment Outcome; Trichophyton | 2017 |
Fatal hepatitis after long-term pulse itraconazole treatment for onychomycosis.
Topics: Antifungal Agents; Chemical and Drug Induced Liver Injury; Fatal Outcome; Female; Foot Dermatoses; Humans; Itraconazole; Middle Aged; Onychomycosis | 2008 |
Maculopapular eruption secondary to itraconazole.
Topics: Adult; Antifungal Agents; Drug Eruptions; Exanthema; Female; Humans; Itraconazole; Onychomycosis | 2008 |
Onychomycosis caused by Fusarium sp in Sri Lanka: prevalence, clinical features and response to itraconazole pulse therapy in six cases.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Cohort Studies; Female; Foot Dermatoses; Fusarium; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Prevalence; Sri Lanka | 2008 |
Onychomycosis: therapy directed by morphology and mycology.
Topics: Antifungal Agents; Humans; Itraconazole; Nails; Naphthalenes; Onychomycosis; Terbinafine | 2009 |
Onychomycosis caused by Aspergillus versicolor.
Topics: Aged; Antifungal Agents; Aspergillus; Female; Humans; Hyphae; Itraconazole; Microscopy; Mycology; Nails; Onychomycosis; Spores, Fungal; Toes | 2010 |
Onychomycosis: report on experience with itraconazole in 37 patients aged older than 50 years: a multivariate regression.
Topics: Aged; Antifungal Agents; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Multivariate Analysis; Onychomycosis | 2009 |
Onychomycosis caused by Nigrospora sphaerica in an immunocompetent man.
Topics: Antifungal Agents; DNA, Fungal; Foot Dermatoses; Humans; Immunocompetence; Itraconazole; Male; Mitosporic Fungi; Onychomycosis; Sequence Analysis, DNA; Young Adult | 2009 |
Onychomycosis in psoriatic patients - rationalization of systemic treatment.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Child, Preschool; Female; Humans; Itraconazole; Male; Middle Aged; Nails; Onychomycosis; Prevalence; Psoriasis; Treatment Outcome; Young Adult | 2010 |
In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Topics: Analysis of Variance; Antifungal Agents; Arthrodermataceae; Candida; Colombia; Dose-Response Relationship, Drug; Fluconazole; Fungi; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2010 |
[Usefulness of pathological diagnosis for two cases of candidal onychomycosis].
Topics: Aged, 80 and over; Antifungal Agents; Biopsy; Candida albicans; Candidiasis, Cutaneous; Female; Hand Dermatoses; Humans; Itraconazole; Male; Onychomycosis; Treatment Outcome | 2009 |
A new species, Aspergillus persii, as an agent of onychomycosis.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Female; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine | 2010 |
Onychomycosis caused by Fusarium solani in a woman with diabetes.
Topics: Aged, 80 and over; Antifungal Agents; Diabetes Complications; Diabetic Foot; Female; Fusarium; Humans; Itraconazole; Onychomycosis; Prognosis; Treatment Outcome | 2009 |
Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents.
Topics: Acremonium; Adult; Antifungal Agents; Aspergillus; Female; Fluconazole; Foot Dermatoses; Fusarium; Humans; Itraconazole; Male; Middle Aged; Morpholines; Naphthalenes; Onychomycosis; Polymorphism, Restriction Fragment Length; Terbinafine | 2010 |
Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents.
Topics: Adult; Aged; Antifungal Agents; Arthrodermataceae; Female; Foot Dermatoses; Humans; Itraconazole; Lacquer; Male; Middle Aged; Morpholines; Nails; Naphthalenes; Onychomycosis; Prospective Studies; Recurrence; Terbinafine; Treatment Outcome | 2010 |
Commentary: the illusory tinea unguium cure.
Topics: Aged; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Prospective Studies; Recurrence; Terbinafine; Trichophyton | 2010 |
Isolation of Fusarium sp. from a claw of a dog with onychomycosis.
Topics: Animals; Antifungal Agents; Base Sequence; DNA, Fungal; DNA, Ribosomal Spacer; Dog Diseases; Dogs; Foot Dermatoses; Fusariosis; Fusarium; Histocytochemistry; Hoof and Claw; Itraconazole; Male; Molecular Sequence Data; Onychomycosis; Polymerase Chain Reaction | 2011 |
Onychomycosis: first case due to Aspergillus nomius.
Topics: Administration, Oral; Antifungal Agents; Aspergillus; Female; Foot Dermatoses; Humans; Itraconazole; Middle Aged; Onychomycosis; Treatment Outcome | 2011 |
Longitudinal melanonychia caused by Fusarium oxysporum in immunocompetent patient.
Topics: Antifungal Agents; DNA, Fungal; DNA, Intergenic; Female; Fusarium; Hand Dermatoses; Humans; Immunocompetence; Itraconazole; Middle Aged; Mycological Typing Techniques; Onychomycosis | 2012 |
Hypothyroidism-related onycholysis with Aureobasidium pullulans colonization successfully treated with antifungal therapy.
Topics: Adult; Antifungal Agents; Ascomycota; Female; Hand Dermatoses; Humans; Hypothyroidism; Imidazoles; Itraconazole; Onycholysis; Onychomycosis; Treatment Outcome | 2012 |
Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.
Topics: Antifungal Agents; Aspergillus; Candida; Cryptococcus; Itraconazole; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Pseudallescheria; Scopulariopsis; Terbinafine; Triazoles; Trichophyton; Trichosporon | 2013 |
[Pharmacoeconomic approach to onychomycosis therapy].
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Military Personnel; Naphthalenes; Onychomycosis; Terbinafine | 2002 |
Trichosporon beigelii infection presenting as white piedra and onychomycosis in the same patient.
Topics: Antifungal Agents; Clotrimazole; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Piedra; Treatment Outcome; Trichosporon | 2002 |
Beau's lines associated with itraconazole.
Topics: Administration, Oral; Antifungal Agents; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Nail Diseases; Onychomycosis; Risk Assessment | 2002 |
Cabergoline plasma concentration is increased during concomitant treatment with itraconazole.
Topics: Adult; Aged; Antifungal Agents; Antiparkinson Agents; Cabergoline; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Ergolines; Female; Humans; Itraconazole; Male; Neurologic Examination; Onychomycosis; Parkinson Disease; Treatment Outcome | 2002 |
[A frequently underestimated dermatomycosis. Long-term therapeutic success with fungicidal effect].
Topics: Antifungal Agents; Clinical Trials as Topic; Drug Administration Schedule; Follow-Up Studies; Humans; Itraconazole; Long-Term Care; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 2002 |
Analysis of the factors influencing the therapeutic effects of onychomycosis.
Topics: Adolescent; Adult; Antifungal Agents; Child; Female; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Treatment Outcome | 2001 |
Fungal nail infection: assessing the new treatment options.
Topics: Antifungal Agents; Foot Dermatoses; Hand Dermatoses; Immunocompromised Host; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2003 |
Guidelines for treatment of onychomycosis.
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Dermatomycoses; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Failure | 2003 |
Onychomycosis: current treatment options.
Topics: Antifungal Agents; Ciclopirox; Female; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Patient Education as Topic; Pyridones | 2003 |
An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Probability; Pulse Therapy, Drug; Retrospective Studies; Severity of Illness Index; Sex Factors; Terbinafine; Treatment Outcome | 2003 |
Curvularia--favorable response to oral itraconazole therapy in two patients with locally invasive phaeohyphomycosis.
Topics: Administration, Oral; Adult; Antifungal Agents; Ascomycota; Humans; Immunocompromised Host; Itraconazole; Male; Middle Aged; Mycoses; Onychomycosis; Sinusitis | 2003 |
[Onychomycosis].
Topics: Antifungal Agents; Ciclopirox; Debridement; Diagnosis, Differential; Drug Therapy, Combination; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Morpholines; Mycological Typing Techniques; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Time Factors | 2004 |
[Modern antimycotics. What the treating physician needs to know].
Topics: Antifungal Agents; Arthrodermataceae; Child; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine; Time Factors | 2004 |
Clinical and pharmacokinetic studies of continuous itraconazole for the treatment of onychomycosis.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Drug Administration Schedule; Female; Humans; Itraconazole; Male; Middle Aged; Nails; Onychomycosis; Treatment Outcome | 2004 |
[A case of dystrophic fingernail].
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Drug Administration Schedule; Hand Dermatoses; Humans; Imidazoles; Itraconazole; Male; Onychomycosis; Species Specificity | 2004 |
Combination treatment of candidal fingernail onychomycosis.
Topics: Antifungal Agents; Candidiasis; Drug Costs; Drug Therapy, Combination; Humans; Itraconazole; Morpholines; Onychomycosis | 2004 |
Liver failure and transplantation after itraconazole treatment for toenail onychomycosis.
Topics: Adult; Antifungal Agents; Female; Foot Dermatoses; Humans; Itraconazole; Liver Failure; Liver Function Tests; Liver Transplantation; Onychomycosis | 2005 |
Subungual hyperkeratosis of the big toe due to Bipolaris hawaiiensis.
Topics: Adult; Antifungal Agents; Female; Foot Dermatoses; Humans; Itraconazole; Keratosis; Mitosporic Fungi; Onychomycosis | 2004 |
Onychomycosis caused by Fusarium proliferatum.
Topics: Antifungal Agents; Foot Dermatoses; Fusarium; Genes, Fungal; Hand Dermatoses; Humans; Itraconazole; Japan; Male; Middle Aged; Onychomycosis; Pulse Therapy, Drug; Sequence Analysis, DNA | 2005 |
Disseminated subcutaneous nodules caused by Pseudallescheria boydii in an atopic patient.
Topics: Administration, Oral; Adult; Antifungal Agents; CD8-Positive T-Lymphocytes; Dermatitis, Atopic; Female; HMGB1 Protein; Humans; Injections, Intralesional; Itraconazole; Killer Cells, Natural; Lymphocyte Count; Mycetoma; Onychomycosis; Pseudallescheria; Stroke; Treatment Outcome; Trichophyton | 2006 |
[The treatment of extensive onychomycosis in aged patients].
Topics: Aged; Aged, 80 and over; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Middle Aged; Morpholines; Nails; Onychomycosis; Treatment Outcome | 2001 |
Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A).
Topics: Antifungal Agents; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine; Trichophyton | 2007 |
[Bilateral proximal cellulitis and onychomycosis in both big toes due to Fusarium solani].
Topics: Antifungal Agents; Cellulitis; Ciclopirox; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Resistance, Multiple, Fungal; Foot Dermatoses; Fusarium; Humans; Imidazoles; Immunocompetence; Itraconazole; Male; Middle Aged; Mozambique; Onychomycosis; Pyridones; Pyrimidines; Recurrence; Toes; Travel; Triazoles; Urea; Voriconazole | 2006 |
Onychocryptosis as consequence of effective treatment of dermatophytic onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Nails, Ingrown; Naphthalenes; Onychomycosis; Retrospective Studies; Terbinafine; Treatment Outcome | 2007 |
Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Ciclopirox; Fluconazole; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Pyridones; Terbinafine | 2007 |
Fusarium spp. as agents of onychomycosis in immunocompetent hosts.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Brazil; Female; Fluconazole; Foot Dermatoses; Fusarium; Humans; Immunocompetence; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Onychomycosis; Terbinafine | 2007 |
Frequent premature ventricular contractions induced by itraconazole.
Topics: Adult; Electrocardiography; Humans; Itraconazole; Male; Onychomycosis; Ventricular Premature Complexes | 2007 |
Delivery of itraconazole from extruded HPC films.
Topics: Administration, Topical; alpha-Tocopherol; Antifungal Agents; Antioxidants; Calorimetry, Differential Scanning; Cellulose; Chromatography, High Pressure Liquid; Crystallization; Delayed-Action Preparations; Drug Carriers; Drug Stability; Itraconazole; Kinetics; Molecular Weight; Onychomycosis; Technology, Pharmaceutical; Thermogravimetry; X-Ray Diffraction | 2007 |
In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
Topics: Adult; Antifungal Agents; Dose-Response Relationship, Drug; Drug Evaluation; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Trichophyton | 2007 |
[Resistance to azolic compounds in clinical Trichophyton spp. strains].
Topics: Adult; Antifungal Agents; Cross Infection; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Epidermophyton; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Mexico; Microsporum; Onychomycosis; Tinea; Tinea Capitis; Tinea Pedis; Trichophyton | 2007 |
Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Foot Dermatoses; Humans; Itraconazole; Male; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 2008 |
Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis.
Topics: Antifungal Agents; Arthrodermataceae; Culture Media; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine | 2008 |
Itraconazole concentrations of fingernails and toenails of patients with tinea unguium.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Onychomycosis | 2008 |
Onychomycosis by Chaetomium spp.
Topics: Animals; Antifungal Agents; Chaetomium; Child; Female; Humans; Itraconazole; Miconazole; Onychomycosis | 2009 |
[Oral treatment of onychomycosis of the toe nails; comparison of cost effectiveness of griseofulvin, itraconazole, ketoconazole and terbinafine].
Topics: Antifungal Agents; Cost-Benefit Analysis; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1995 |
Onychomycosis caused by Microsporum canis: treatment with itraconazole.
Topics: Adult; Female; Humans; Itraconazole; Microsporum; Onychomycosis | 1995 |
[Oral treatment of onychomycosis of the toe nails; comparison of cost-effectiveness of griseofulvin, itraconazole, ketoconazole and terbinafine].
Topics: Administration, Oral; Antifungal Agents; Cost-Benefit Analysis; Drug Costs; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Oxygenases; Terbinafine; Toes | 1994 |
Debilitating edema associated with itraconazole therapy.
Topics: Aged; Edema; Female; Hand; Humans; Itraconazole; Leg; Male; Middle Aged; Onychomycosis | 1994 |
[Liver damage during administration of itraconazole (Trisporal)].
Topics: Aged; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Chemical and Drug Induced Liver Injury; Female; Humans; Itraconazole; Ketoconazole; Liver Function Tests; Male; Middle Aged; Onychomycosis | 1993 |
Itraconazole for onychomycosis.
Topics: Antifungal Agents; Clinical Trials as Topic; Drug Costs; Drug Interactions; Humans; Itraconazole; Onychomycosis | 1996 |
New drugs for the nail fungus prevalent in elderly.
Topics: Aged; Antifungal Agents; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1996 |
Lateral edge nail involvement indicates poor prognosis for treating onychomycosis with the new systemic antifungals.
Topics: Antifungal Agents; Hand Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Prognosis; Terbinafine | 1996 |
New therapies for onychomycosis.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1996 |
Ethics and micromanaged care.
Topics: Antifungal Agents; Dermatology; Disclosure; Ethics, Medical; Foot Dermatoses; Humans; Itraconazole; Male; Managed Care Programs; Middle Aged; Onychomycosis; Risk Assessment; Tinea Pedis; United States | 1996 |
Yellow nail syndrome and onychomycosis. Experience with itraconazole pulse therapy combined with vitamin E.
Topics: Adult; Antifungal Agents; Bronchial Diseases; Drug Therapy, Combination; Female; Humans; Itraconazole; Nail Diseases; Onychomycosis; Pigmentation Disorders; Sinusitis; Syndrome; Vitamin E | 1996 |
Plantar infection by Scopulariopsis brevicaulis.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Antifungal Agents; Dermatomycoses; Drug Resistance, Microbial; Erythema; Female; Foot Dermatoses; Humans; Imidazoles; Itraconazole; Mitosporic Fungi; Naphthalenes; Onychomycosis; Pruritus; Recurrence; Terbinafine | 1996 |
Itraconazole therapy for onychomycosis: case reports.
Topics: Aged; Antifungal Agents; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Treatment Outcome | 1996 |
Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany.
Topics: Algorithms; Antifungal Agents; Ciclopirox; Cost-Benefit Analysis; Costs and Cost Analysis; Decision Trees; Drug Administration Schedule; Drug Costs; Evaluation Studies as Topic; Follow-Up Studies; Foot Dermatoses; Germany; Health Resources; Humans; Itraconazole; Meta-Analysis as Topic; Naphthalenes; Onychomycosis; Paint; Practice Patterns, Physicians'; Pyridones; Sensitivity and Specificity; Terbinafine | 1996 |
Onychomycosis due to Scopulariopsis brevicaulis: clinical features and response to systemic antifungals.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Female; Humans; Itraconazole; Male; Middle Aged; Nails; Naphthalenes; Onychomycosis; Terbinafine; Toes; Treatment Outcome | 1996 |
Onychomycosis. New therapies for an old disease.
Topics: Aged; Antifungal Agents; Female; Foot Dermatoses; Humans; Itraconazole; Male; Naphthalenes; Onychomycosis; Terbinafine; Trichophyton | 1996 |
[Info-congress. Itraconazole in the treatment of dermatomycoses and onychomycoses. Current concept of intermittent therapy using weekly units repeated monthly].
Topics: Antifungal Agents; Dermatomycoses; Humans; Itraconazole; Onychomycosis; Quality of Life | 1996 |
[News in the therapy of onychomycoses (Itraconazole)].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Dermatomycoses; Drug Interactions; Humans; Itraconazole; Onychomycosis | 1995 |
Long-term results of patients with onychomycosis treated with itraconazole.
Topics: Antifungal Agents; Drug Administration Schedule; Follow-Up Studies; Humans; Itraconazole; Onychomycosis; Toes; Treatment Outcome | 1997 |
[Itraconazol--new in the systemic management of onychomycoses].
Topics: Antifungal Agents; Humans; Itraconazole; Onychomycosis | 1995 |
Effect of Lamisil and azole antifungals in experimental nail infection.
Topics: Antifungal Agents; Arthrodermataceae; Candida albicans; Candidiasis; Dermatomycoses; Dose-Response Relationship, Drug; Fingers; Humans; In Vitro Techniques; Itraconazole; Microscopy, Electron; Models, Theoretical; Naphthalenes; Onychomycosis; Terbinafine; Tinea; Trichophyton | 1997 |
Onychomycosis--a different perspective.
Topics: Antifungal Agents; Arthrodermataceae; Cost-Benefit Analysis; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Recurrence; Terbinafine | 1997 |
[How I treat onychomycosis using pulsed therapy].
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Diagnosis, Differential; Drug Administration Schedule; Fluconazole; Humans; Itraconazole; Nail Diseases; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
Contempo 1997: dermatology.
Topics: Antifungal Agents; Contraceptives, Oral; Drug Interactions; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
Trichophyton rubrum onychomycosis in a 17-year-old girl.
Topics: Adolescent; Antifungal Agents; Female; Humans; Itraconazole; Onychomycosis | 1997 |
Purpuric drug eruption secondary to itraconazole.
Topics: Aged; Antifungal Agents; Drug Eruptions; Erythema; Female; Foot Dermatoses; Humans; Hyperpigmentation; Itraconazole; Onychomycosis; Purpura | 1997 |
Unusual clinical features of fingernail infection by Fusarium oxysporum.
Topics: Adult; Aged; Antifungal Agents; Female; Fusarium; Hand Dermatoses; Humans; Itraconazole; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
Ungual phaeohyphomycosis caused by Alternaria alternata.
Topics: Aged; Alternaria; Antifungal Agents; Hand Dermatoses; Humans; Itraconazole; Keratosis; Male; Onychomycosis | 1997 |
Long-term remission of two feet-one hand syndrome.
Topics: Adult; Antifungal Agents; Hand Dermatoses; Humans; Itraconazole; Male; Onychomycosis; Syndrome; Tinea Pedis; Trichophyton | 1998 |
Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison.
Topics: Antifungal Agents; Arthrodermataceae; Candida; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine | 1998 |
Aspergillus versicolor as cause of onychomycosis: report of 12 cases and susceptibility testing to antifungal drugs.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Female; Foot Dermatoses; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Onychomycosis; Spain; Terbinafine | 1998 |
Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up.
Topics: Antifungal Agents; Follow-Up Studies; Foot Dermatoses; Humans; Itraconazole; Nails; Naphthalenes; Onychomycosis; Randomized Controlled Trials as Topic; Recurrence; Terbinafine; Time Factors; Tinea; Tinea Pedis; Toes; Trichophyton | 1998 |
[Limits of brief treatment of onychomycoses].
Topics: Administration, Oral; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine; Tinea; Treatment Failure; Trichophyton | 1998 |
Skin and nail infections due to Fusarium oxysporum in Tuscany, Italy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Dermatomycoses; Foot Dermatoses; Fusarium; Humans; Intertrigo; Itraconazole; Male; Microscopy, Electron, Scanning; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1998 |
[Pediatric onychomycosis treated with oral antifungal drugs].
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Female; Fluconazole; Humans; Itraconazole; Male; Onychomycosis | 1999 |
A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine.
Topics: Antifungal Agents; Clinical Laboratory Techniques; Cost-Benefit Analysis; Drug Costs; Drug Interactions; Griseofulvin; Health Maintenance Organizations; Humans; Itraconazole; Naphthalenes; New Jersey; Onychomycosis; Outcome Assessment, Health Care; Recurrence; Terbinafine; Transaminases | 1997 |
Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.
Topics: Antifungal Agents; Costs and Cost Analysis; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; United States | 1998 |
Oral treatment of onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Reproducibility of Results; Terbinafine; Treatment Outcome | 1999 |
Trichophyton tonsurans as a cause of onychomycosis.
Topics: Adult; Antifungal Agents; Humans; Itraconazole; Male; Onychomycosis; Trichophyton | 1999 |
Continuous terbinafine versus intermittent itraconazole for toenail onychomycosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Foot Dermatoses; Humans; Itraconazole; Male; Middle Aged; Multicenter Studies as Topic; Naphthalenes; Onychomycosis; Prospective Studies; Randomized Controlled Trials as Topic; Terbinafine; Treatment Outcome | 1999 |
White superficial onychomycosis of the fingernail caused by Trichophyton rubrum in an immunocompetent patient.
Topics: Adult; Antifungal Agents; Hand Dermatoses; Humans; Immunocompetence; Itraconazole; Male; Onychomycosis; Trichophyton | 1999 |
Update on superficial fungal infections. Introduction.
Topics: Administration, Oral; Antifungal Agents; Dermatomycoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1999 |
Safety of itraconazole pulse therapy for onychomycosis. An update.
Topics: Aged; Antifungal Agents; Drug Administration Schedule; Female; Humans; Itraconazole; Liver Function Tests; Naphthalenes; Onychomycosis; Pregnancy; Terbinafine | 1999 |
Severe cholestasis related to intraconazole for the treatment of onychomycosis.
Topics: Aged; Antifungal Agents; Bilirubin; Cholestasis, Intrahepatic; Humans; Itraconazole; Liver Function Tests; Male; Onychomycosis | 1999 |
The cost effectiveness of testing for onychomycosis versus empiric treatment of onychodystrophies with oral antifungal agents.
Topics: Administration, Oral; Antifungal Agents; Cost-Benefit Analysis; Diagnosis, Differential; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1999 |
The use of systemic antimycotics in dermatotherapy.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Cost-Benefit Analysis; Dermatomycoses; Fluconazole; Griseofulvin; Hair Diseases; Humans; Itraconazole; Ketoconazole; Naphthalenes; Odds Ratio; Onychomycosis; Terbinafine; Tinea | 2000 |
Non-dermatophytic onychomycosis. An understimated entity? A study of 51 cases.
Topics: Antifungal Agents; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2000 |
Intermittent pulse therapy with itraconazole for onychomycosis. Experience in Hong Kong Chinese.
Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Female; Foot Dermatoses; Hand Dermatoses; Hong Kong; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Treatment Outcome | 2000 |
Case report. Onychomycosis due to Chaetomium globosum successfully treated with itraconazole.
Topics: Antifungal Agents; Chaetomium; Foot Dermatoses; Humans; Itraconazole; Japan; Male; Middle Aged; Onychomycosis; Treatment Outcome | 2000 |
Onychomycosis treated until the nail is replaced by normal growth or there is failure.
Topics: Antifungal Agents; Drug Administration Schedule; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2000 |
Amino acid- or protein-dependent growth of Trichophyton mentagrophytes and Trichophyton rubrum.
Topics: Amino Acids; Antifungal Agents; Culture Media; Electrophoresis, Polyacrylamide Gel; Humans; Itraconazole; Nails; Naphthalenes; Onychomycosis; Proteins; Terbinafine; Trichophyton | 2000 |
Long-term follow-up study of onychomycosis: cure rate and dropout rate with oral antifungal treatments.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Female; Follow-Up Studies; Foot Dermatoses; Griseofulvin; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Regression Analysis; Retrospective Studies; Treatment Outcome | 2001 |
Itraconazole now indicated to treat fungal nail disease.
Topics: Antifungal Agents; Humans; Itraconazole; Liver; Onychomycosis | 1996 |
Onychomycosis in Tehran, Iran: prevailing fungi and treatment with itraconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Arthrodermataceae; Candida; Child; Dermatomycoses; Female; Foot Dermatoses; Hand Dermatoses; Humans; Iran; Itraconazole; Male; Middle Aged; Onychomycosis; Trichophyton | 2001 |
Congestive heart failure associated with itraconazole.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Antifungal Agents; Female; Heart Failure; Humans; Itraconazole; Male; Middle Aged; Onychomycosis | 2001 |
Case report. Onychomycosis due to Microsporum canis.
Topics: Aged; Animals; Antifungal Agents; Asthma; Carrier State; Cat Diseases; Cats; Foot Dermatoses; Hair; Humans; Itraconazole; Male; Microsporum; Onychomycosis; Pulse Therapy, Drug | 2001 |
Onychomycosis caused by Alternaria spp. in Tuscany, Italy from 1985 to 1999.
Topics: Aged; Alternaria; Antifungal Agents; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Italy; Itraconazole; Keratosis; Male; Middle Aged; Onychomycosis; Treatment Outcome | 2001 |
[Pancreatitis ascribed to the use of itraconazole].
Topics: Acute Disease; Antifungal Agents; Female; Humans; Itraconazole; Middle Aged; Onychomycosis; Pancreatitis; Recurrence; Retreatment | 2001 |
Intermittent low dose itraconazole treatment for onychomycosis--long term follow-up.
Topics: Adult; Aged; Antifungal Agents; Female; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Onychomycosis | 2001 |
[Intermittent-pulse treatment of onychomycosis with orally administered itraconazole].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Male; Middle Aged; Onychomycosis; Pulse Therapy, Drug | 1999 |
Proximal white subungual onychomycosis caused by Microsporum canis in systemic lupus erythematosus.
Topics: Adult; Antifungal Agents; Female; Humans; Itraconazole; Lupus Erythematosus, Systemic; Microsporum; Onychomycosis; Treatment Outcome | 2002 |
[Diversified treatments of Tinea unguium].
Topics: Administration, Oral; Antifungal Agents; Combined Modality Therapy; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Occlusive Dressings; Onychomycosis; Pulse Therapy, Drug; Terbinafine | 2002 |
Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis.
Topics: Antifungal Agents; Capsules; Chromatography, High Pressure Liquid; Drug Evaluation; Female; Fingers; Humans; Itraconazole; Ketoconazole; Male; Nails; Onychomycosis; Remission Induction; Time Factors; Toes | 1992 |
[New treatments of onychomycoses].
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Ciclopirox; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Morpholines; Onychomycosis; Pyridones | 1992 |
Itraconazole penetrates the nail via the nail matrix and the nail bed--an investigation in onychomycosis.
Topics: Adult; Aged; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Nails; Onychomycosis | 1991 |
An evaluation of itraconazole in the management of onychomycosis.
Topics: Adult; Aged; Antifungal Agents; Drug Evaluation; Female; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Onychomycosis | 1988 |